ARTICLE | Company News
Cantab Biopharmaceuticals, PolyTherics deal
February 1, 2010 8:00 AM UTC
The companies will use PolyTherics' TheraPEG pegylation technology to develop an undisclosed preclinical protein therapeutic in the area of hematology. Celtic Pharma Holdings Advisors LLP, which owns ...